The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Neurovascular Embolic Protection Device Market Research Report 2024

Global Neurovascular Embolic Protection Device Market Research Report 2024

Publishing Date : Jun, 2023

License Type :
 

Report Code : 1743939

No of Pages : 98

Ask Your Query

Synopsis
Global Neurovascular Embolic Protection Device market is projected to reach US$ 718.1 million in 2029, increasing from US$ 400 million in 2022, with the CAGR of 8.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neurovascular Embolic Protection Device market research.

Key manufacturers engaged in the Neurovascular Embolic Protection Device industry include InspireMD, Inc., Boston Scientific Corporation, Abbott Laboratories, Medtronic plc, Cardinal Health, Contego Medical, LLC, Silk Road Medical, Inc., Edwards and Lifesciences Corporation, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Neurovascular Embolic Protection Device were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Neurovascular Embolic Protection Device market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Neurovascular Embolic Protection Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • InspireMD, Inc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Medtronic plc
  • Cardinal Health
  • Contego Medical, LLC
  • Silk Road Medical, Inc.
  • Edwards
  • Lifesciences Corporation
  • Lepu Medical Technology

Segment by Type

  • Distal Occlusion Devices
  • Proximal Occlusion Devices
  • Distal Filters

Segment by Application

  • Hospitals & Clinics
  • Ambulatoy Surgery Centers
  • Others

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Neurovascular Embolic Protection Device report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Neurovascular Embolic Protection Device Market Overview
1.1 Product Overview and Scope of Neurovascular Embolic Protection Device
1.2 Neurovascular Embolic Protection Device Segment by Type
1.2.1 Global Neurovascular Embolic Protection Device Market Value Comparison by Type (2023-2029)
1.2.2 Distal Occlusion Devices
1.2.3 Proximal Occlusion Devices
1.2.4 Distal Filters
1.3 Neurovascular Embolic Protection Device Segment by Application
1.3.1 Global Neurovascular Embolic Protection Device Market Value by Application: (2023-2029)
1.3.2 Hospitals & Clinics
1.3.3 Ambulatoy Surgery Centers
1.3.4 Others
1.4 Global Neurovascular Embolic Protection Device Market Size Estimates and Forecasts
1.4.1 Global Neurovascular Embolic Protection Device Revenue 2018-2029
1.4.2 Global Neurovascular Embolic Protection Device Sales 2018-2029
1.4.3 Global Neurovascular Embolic Protection Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Neurovascular Embolic Protection Device Market Competition by Manufacturers
2.1 Global Neurovascular Embolic Protection Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Neurovascular Embolic Protection Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Neurovascular Embolic Protection Device Average Price by Manufacturers (2018-2023)
2.4 Global Neurovascular Embolic Protection Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Neurovascular Embolic Protection Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurovascular Embolic Protection Device, Product Type & Application
2.7 Neurovascular Embolic Protection Device Market Competitive Situation and Trends
2.7.1 Neurovascular Embolic Protection Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurovascular Embolic Protection Device Players Market Share by Revenue
2.7.3 Global Neurovascular Embolic Protection Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurovascular Embolic Protection Device Retrospective Market Scenario by Region
3.1 Global Neurovascular Embolic Protection Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Neurovascular Embolic Protection Device Global Neurovascular Embolic Protection Device Sales by Region: 2018-2029
3.2.1 Global Neurovascular Embolic Protection Device Sales by Region: 2018-2023
3.2.2 Global Neurovascular Embolic Protection Device Sales by Region: 2024-2029
3.3 Global Neurovascular Embolic Protection Device Global Neurovascular Embolic Protection Device Revenue by Region: 2018-2029
3.3.1 Global Neurovascular Embolic Protection Device Revenue by Region: 2018-2023
3.3.2 Global Neurovascular Embolic Protection Device Revenue by Region: 2024-2029
3.4 North America Neurovascular Embolic Protection Device Market Facts & Figures by Country
3.4.1 North America Neurovascular Embolic Protection Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Neurovascular Embolic Protection Device Sales by Country (2018-2029)
3.4.3 North America Neurovascular Embolic Protection Device Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurovascular Embolic Protection Device Market Facts & Figures by Country
3.5.1 Europe Neurovascular Embolic Protection Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Neurovascular Embolic Protection Device Sales by Country (2018-2029)
3.5.3 Europe Neurovascular Embolic Protection Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurovascular Embolic Protection Device Market Facts & Figures by Country
3.6.1 Asia Pacific Neurovascular Embolic Protection Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Neurovascular Embolic Protection Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Neurovascular Embolic Protection Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Neurovascular Embolic Protection Device Market Facts & Figures by Country
3.7.1 Latin America Neurovascular Embolic Protection Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Neurovascular Embolic Protection Device Sales by Country (2018-2029)
3.7.3 Latin America Neurovascular Embolic Protection Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Neurovascular Embolic Protection Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurovascular Embolic Protection Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Neurovascular Embolic Protection Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Neurovascular Embolic Protection Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurovascular Embolic Protection Device Sales by Type (2018-2029)
4.1.1 Global Neurovascular Embolic Protection Device Sales by Type (2018-2023)
4.1.2 Global Neurovascular Embolic Protection Device Sales by Type (2024-2029)
4.1.3 Global Neurovascular Embolic Protection Device Sales Market Share by Type (2018-2029)
4.2 Global Neurovascular Embolic Protection Device Revenue by Type (2018-2029)
4.2.1 Global Neurovascular Embolic Protection Device Revenue by Type (2018-2023)
4.2.2 Global Neurovascular Embolic Protection Device Revenue by Type (2024-2029)
4.2.3 Global Neurovascular Embolic Protection Device Revenue Market Share by Type (2018-2029)
4.3 Global Neurovascular Embolic Protection Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Neurovascular Embolic Protection Device Sales by Application (2018-2029)
5.1.1 Global Neurovascular Embolic Protection Device Sales by Application (2018-2023)
5.1.2 Global Neurovascular Embolic Protection Device Sales by Application (2024-2029)
5.1.3 Global Neurovascular Embolic Protection Device Sales Market Share by Application (2018-2029)
5.2 Global Neurovascular Embolic Protection Device Revenue by Application (2018-2029)
5.2.1 Global Neurovascular Embolic Protection Device Revenue by Application (2018-2023)
5.2.2 Global Neurovascular Embolic Protection Device Revenue by Application (2024-2029)
5.2.3 Global Neurovascular Embolic Protection Device Revenue Market Share by Application (2018-2029)
5.3 Global Neurovascular Embolic Protection Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 InspireMD, Inc.
6.1.1 InspireMD, Inc. Corporation Information
6.1.2 InspireMD, Inc. Description and Business Overview
6.1.3 InspireMD, Inc. Neurovascular Embolic Protection Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 InspireMD, Inc. Neurovascular Embolic Protection Device Product Portfolio
6.1.5 InspireMD, Inc. Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Neurovascular Embolic Protection Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boston Scientific Corporation Neurovascular Embolic Protection Device Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories Neurovascular Embolic Protection Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Laboratories Neurovascular Embolic Protection Device Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Medtronic plc
6.4.1 Medtronic plc Corporation Information
6.4.2 Medtronic plc Description and Business Overview
6.4.3 Medtronic plc Neurovascular Embolic Protection Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medtronic plc Neurovascular Embolic Protection Device Product Portfolio
6.4.5 Medtronic plc Recent Developments/Updates
6.5 Cardinal Health
6.5.1 Cardinal Health Corporation Information
6.5.2 Cardinal Health Description and Business Overview
6.5.3 Cardinal Health Neurovascular Embolic Protection Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cardinal Health Neurovascular Embolic Protection Device Product Portfolio
6.5.5 Cardinal Health Recent Developments/Updates
6.6 Contego Medical, LLC
6.6.1 Contego Medical, LLC Corporation Information
6.6.2 Contego Medical, LLC Description and Business Overview
6.6.3 Contego Medical, LLC Neurovascular Embolic Protection Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Contego Medical, LLC Neurovascular Embolic Protection Device Product Portfolio
6.6.5 Contego Medical, LLC Recent Developments/Updates
6.7 Silk Road Medical, Inc.
6.6.1 Silk Road Medical, Inc. Corporation Information
6.6.2 Silk Road Medical, Inc. Description and Business Overview
6.6.3 Silk Road Medical, Inc. Neurovascular Embolic Protection Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Silk Road Medical, Inc. Neurovascular Embolic Protection Device Product Portfolio
6.7.5 Silk Road Medical, Inc. Recent Developments/Updates
6.8 Edwards
6.8.1 Edwards Corporation Information
6.8.2 Edwards Description and Business Overview
6.8.3 Edwards Neurovascular Embolic Protection Device Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Edwards Neurovascular Embolic Protection Device Product Portfolio
6.8.5 Edwards Recent Developments/Updates
6.9 Lifesciences Corporation
6.9.1 Lifesciences Corporation Corporation Information
6.9.2 Lifesciences Corporation Description and Business Overview
6.9.3 Lifesciences Corporation Neurovascular Embolic Protection Device Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Lifesciences Corporation Neurovascular Embolic Protection Device Product Portfolio
6.9.5 Lifesciences Corporation Recent Developments/Updates
6.10 Lepu Medical Technology
6.10.1 Lepu Medical Technology Corporation Information
6.10.2 Lepu Medical Technology Description and Business Overview
6.10.3 Lepu Medical Technology Neurovascular Embolic Protection Device Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Lepu Medical Technology Neurovascular Embolic Protection Device Product Portfolio
6.10.5 Lepu Medical Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurovascular Embolic Protection Device Industry Chain Analysis
7.2 Neurovascular Embolic Protection Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurovascular Embolic Protection Device Production Mode & Process
7.4 Neurovascular Embolic Protection Device Sales and Marketing
7.4.1 Neurovascular Embolic Protection Device Sales Channels
7.4.2 Neurovascular Embolic Protection Device Distributors
7.5 Neurovascular Embolic Protection Device Customers
8 Neurovascular Embolic Protection Device Market Dynamics
8.1 Neurovascular Embolic Protection Device Industry Trends
8.2 Neurovascular Embolic Protection Device Market Drivers
8.3 Neurovascular Embolic Protection Device Market Challenges
8.4 Neurovascular Embolic Protection Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock